Shares of Science Applications International Corporation SAIC declined 11% to $119.91 following first-quarter results.
SAIC reported a 9% revenue decline year over year in the fiscal first quarter of 2025 to $1.847 billion, marginally beating the analyst consensus estimate of $1.844 billion. Adjusted EPS of $1.92 was in line with the analyst consensus estimate, according to data from Benzinga Pro.
SAIC shares dipped 11% to $119.91 on Monday.
Here are some other stocks moving in today’s mid-day session.
Gainers
- Microbot Medical Inc. MBOT jumped 92.5% to $1.9301 after the company received FDA approval to proceed with its pivotal human clinical trial.
- Bio-Path Holdings, Inc. BPTH shares jumped 75% to $3.62. Bio-Path presented interim results from Phase 2 study of Prexigebersen (BP1001) in combination with decitabine and venetoclax for acute myeloid leukemia at the American Society Of Clinical Oncology Annual Meeting.
- GameStop Corp. GME shares climbed 34.5% to $31.13 after Roaring Kitty on a Reddit post, shared his position on the stock.
- Professional Diversity Network, Inc. IPDN gained 28.5% to $0.65. Professional Diversity Network recently named Megan Bozzuto as interim CFO.
- MarineMax, Inc. HZO gained 27% to $36.16. OneWater Marine Inc. is reportedly said to be in advanced discussions to acquire MarineMax.
- Crown ElectroKinetics Corp. CRKN shares rose 27% to $0.1271 after dipping 12% on Friday.
- MingZhu Logistics Holdings Limited YGMZ climbed 26.5% to $0.4425 after the company reported an agreement to acquire Oxylus Global.
- Dogness (International) Corporation DOGZ gained 23.5% to $13.65
- Affimed N.V. AFMD gained 22.2% to $5.25 as the company issued follow-up data of AFM24 plus atezolizumab showing durable responses in heavily pretreated NSCLC EGFR wild-type patients and positive initial data from the NSCLC EGFR mutant cohort.
- Concord Medical Services Holdings Limited CCM rose 17.6% to $0.5883.
- MacroGenics, Inc. MGNX rose 17.5% to $4.8001.
- Personalis, Inc. PSNL gained 17.5% to $1.5282.
- Liquidia Corporation LQDA gained 16.8% to $15.03 as the company said District Court issued favorable ruling and denied United Therapeutics’ request to block YUTREPIA™ launch.
- Olema Pharmaceuticals, Inc. OLMA rose 15.5% to $11.18.
- Stericycle, Inc. SRCL gained 15% to $59.28 after the company announced that it entered into a definitive agreement to be acquired by Waste Management.
- Precigen, Inc. PGEN rose 15% to $1.61 after reporting study data for PRGN-2012 for recurrent respiratory papillomatosis patients.
- Coherent Corp. COHR gained 13.4% to $64.71 after the company announced the appointment of Jim Anderson as CEO.
- CG Oncology, Inc. CGON rose 11.8% to $36.34
- Structure Therapeutics Inc. GPCR rose 11.8% to $38.25 after the company reported 12-week results for obesity drug GSBR-1290, achieving significant weight loss.
- AMC Entertainment Holdings, Inc. AMC gained 11.6% to $4.8330. The resumption of the meme rally came on the back of Keith Gill, also known as "Roaring Kitty," disclosing a substantial position in GameStop on the r/Superstonk Reddit forum.
- Novavax, Inc. NVAX gained 10.7% to $16.65.
- Telephone and Data Systems, Inc. TDS rose 9% to $21.67 as the company agreed to sell its wholly owned subsidiaries OneNeck IT Solutions and OneNeck Data Center to US Signal Company, LLC.
- Faraday Future Intelligent Electric Inc. FFIE shares gained 8.8% to $0.6348 after gaining over 3% on Friday.Â
- Autodesk, Inc. ADSK gained 8.3% to $218.39 after the company issued preliminary results and said there will be no restatement or adjustment of any audited or unaudited financial statements.
- Molecular Partners AG MOLN shares climbed 8.2% to $4.0699. Molecular Partners presented data from completed Phase 1 trial of MP0317 monotherapy in advanced solid tumors at ASCO 2024.
Losers
- CalAmp Corp. CAMP shares fell 61.4% to $1.03 after the company said it has entered into a Restructuring Support Agreement with its principal secured lender, Lynrock Lake Master Fund LP, who will become the principal equity owner of CalAmp and take the Company private.
- Ault Disruptive Technologies Corporation ADRT fell 52.2% to $21.50.
- CNS Pharmaceuticals, Inc. CNSP fell 32.3% to $0.1463. CNS Pharmaceuticals announced a 1-for-50 reverse stock split.
- Galera Therapeutics, Inc. GRTX fell 30% to $0.1536. Galera Therapeutics will be delisted by Nasdaq.
- Portage Biotech Inc PRTG shares fell 29.7% to $0.3365 after gaining over 91% on Friday.
- 1847 Holdings LLC EFSH dipped 29.5% to $0.7895.
- FOXO Technologies Inc. FOXO fell 26.3% to $0.3501.
- iSpecimen Inc. ISPC shares declined 24.4% to $0.3251.
- Webuy Global Ltd WBUY fell 23.7% to $0.1870.
- Direct Digital Holdings, Inc. DRCT fell 21.2% to $2.67.
- Vintage Wine Estates, Inc. VWE fell 19.2% to $0.2883.
- Latam Logistic Properties, S.A. LPA fell 19.2% to $105.00
- Brand Engagement Network, Inc. BNAI shares fell 16.4% to $4.55 after jumping over 110% on Friday.
- Lattice Semiconductor Corporation LSCC fell 15.1% to $63.00 after the company announced an interim CEO following Jim Anderson’s decision to step down as President, CEO and Board member to pursue an opportunity with another company.
- Latam Logistic Properties, S.A. LPA dipped 13.8% to $112.00.
- Digital Health Acquisition Corp DHAC shares fell 10.3% to $15.25 after gaining 13% on Friday.
- Grupo Aeroportuario del Centro Norte, S.A.B. de C.V. OMAB declined 10.2% to $73.44.
- Immunocore Holdings plc IMCR fell 10.1% to $44.05.
- Grupo Aeroportuario del PacÃfico, S.A.B. de C.V. PAC fell 10% to $169.23.
- GSK plc GSK fell 8.7% to $40.87 after the company said it will appeal a ruling made by the Delaware State Court regarding its ongoing ranitidine litigation.
- The Scotts Miracle-Gro Company SMG declined 7.7% to $64.33.
- ZIM Integrated Shipping Services Ltd. ZIM fell 7.7% to $20.81.
- Dell Technologies Inc. DELL fell 7.1% to $129.63. On May 30, Dell reported upbeat earnings and sales results for the first quarter.
- Vistra Corp. VST dipped 6.5% to $92.61.
The Boston Beer Company, Inc. SAM shares fell 4.7% to $299.07. Boston Beer shares jumped around 22% on Friday following a report suggesting the company is in talks to sell itself to Suntory. Boston Beer later issued a statement on the company sale speculation. "We are fully focused on our business as an independent company and our return to growth," the company said.
Now Read This: This MongoDB Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Monday
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.